Trials / Completed
CompletedNCT00314964
Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study Evaluating PD-0299685 for Treatment of Vasomotor Symptoms Associated With Menopause
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 527 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine if PD-0299685 is effective and safe in the treatment of vasomotor symptoms (hot flashes / flushes) associated with menopause.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PD-0299685 |
Timeline
- Start date
- 2006-08-01
- Completion
- 2007-07-01
- First posted
- 2006-04-17
- Last updated
- 2011-03-16
Locations
80 sites across 6 countries: United States, Australia, Canada, France, South Africa, Spain
Source: ClinicalTrials.gov record NCT00314964. Inclusion in this directory is not an endorsement.